{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 1354, "factors": [{"GSM328570 1": {}}, {"GSM328569 1": {}}, {"GSM328568 1": {}}], "ownerprofile_id": "arrayexpress_sid", "platform": 3, "summary_wrapped": "The c-Myb transcription factor is highly expressed in immature hematopoietic cells and down-regulated during differentiation. To define...", "pubmed_id": 20686118, "geo_gse_id": "E-GEOD-13110", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 0, "sample_count": 3, "tags": ["cell", "chromatin", "macrophage", "megakaryocyte", "protein"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "myb-silencing-in-cd34-progenitor-cells", "geo_id_plat": "E-GEOD-13110_A-AFFY-33", "name": "MYB silencing in CD34+ progenitor cells", "created": "Jun.19, 2014", "summary": "The c-Myb transcription factor is highly expressed in immature hematopoietic cells and down-regulated during differentiation. To define the role of c-Myb in human hematopoietic lineage commitment, we studied the effects of its silencing during the commitment of human CD34+ Hematopoietic stem/progenitor cells. In CD34+ cells c-Myb silencing determined a cell cycle arrest in G0/G1 phase which strongly decreased the clonogenic efficiency, togheter with a reduction of erythroid colonies coupled with an increase of the macrophage and megakaryocyte ones. Moreover, morphological and flow cytometry data supported the preferential macrophage and megakaryocyte differentiation of c-Myb-silenced CD34+ cells. Taken together our data indicate that c-Myb is essential for the commitment along the erythroid and granulocyte lineages but not for the macrophage and megakaryocyte differentiation. Gene expression profiling of c-Myb-silenced CD34+ cells identified some potential c-Myb targets which can account for these effects, to study by Chromatin Immunoprecipitation and Luciferase Reporter Assay. To maximize siRNA transfection efficiency, we utilized the NucleofectorTM technology (Amaxa). CD34+ cells were transfected with a mixture of 3 siRNAs targeting c-Myb mRNA and with a non-targeting siRNA as a negative control. The expression level of c-Myb protein on control cells (MOCK and negative control treated cells) and MYBsiRNA treated cells was assessed by Western Blot at 24 and 48h post-nucleofection.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-13110", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-13110/samples/"}